[HTML][HTML] Understanding retinoblastoma post-translational regulation for the design of targeted cancer therapies
Simple Summary Rb1 is a regulator of cell cycle progression and genomic stability. This
review focuses on post-translational modifications, their effect on Rb1 interactors, and their …
review focuses on post-translational modifications, their effect on Rb1 interactors, and their …
Understanding retinoblastoma post-translational regulation for the design of targeted cancer therapies
R Janostiak, A Torres-Sanchez… - … (Basel). 2022 Feb 28; …, 2022 - repositori.upf.edu
The retinoblastoma protein (Rb1) is a prototypical tumor suppressor protein whose role was
described more than 40 years ago. Together with p107 (also known as RBL1) and p130 …
described more than 40 years ago. Together with p107 (also known as RBL1) and p130 …
Understanding Retinoblastoma Post-Translational Regulation for the Design of Targeted Cancer Therapies.
R Janostiak, A Torres-Sanchez, F Posas… - …, 2022 - search.ebscohost.com
Abstract Simple Summary: Rb1 is a regulator of cell cycle progression and genomic stability.
This review focuses on post-translational modifications, their effect on Rb1 interactors, and …
This review focuses on post-translational modifications, their effect on Rb1 interactors, and …
Understanding Retinoblastoma Post-Translational Regulation for the Design of Targeted Cancer Therapies.
R Janostiak, A Torres-Sanchez, F Posas, E de Nadal - Cancers, 2022 - europepmc.org
The retinoblastoma protein (Rb1) is a prototypical tumor suppressor protein whose role was
described more than 40 years ago. Together with p107 (also known as RBL1) and p130 …
described more than 40 years ago. Together with p107 (also known as RBL1) and p130 …
Understanding Retinoblastoma Post-Translational Regulation for the Design of Targeted Cancer Therapies
R Janostiak, A Torres-Sanchez, F Posas… - …, 2022 - pubmed.ncbi.nlm.nih.gov
The retinoblastoma protein (Rb1) is a prototypical tumor suppressor protein whose role was
described more than 40 years ago. Together with p107 (also known as RBL1) and p130 …
described more than 40 years ago. Together with p107 (also known as RBL1) and p130 …
[HTML][HTML] Understanding Retinoblastoma Post-Translational Regulation for the Design of Targeted Cancer Therapies
R Janostiak, A Torres-Sanchez, F Posas, E de Nadal - Cancers, 2022 - ncbi.nlm.nih.gov
The retinoblastoma protein (Rb1) is a prototypical tumor suppressor protein whose role was
described more than 40 years ago. Together with p107 (also known as RBL1) and p130 …
described more than 40 years ago. Together with p107 (also known as RBL1) and p130 …
Understanding Retinoblastoma Post-Translational Regulation for the Design of Targeted Cancer Therapies
R Janostiak, A Torres-Sanchez, F Posas… - Cancers, 2022 - search.proquest.com
The retinoblastoma protein (Rb1) is a prototypical tumor suppressor protein whose role was
described more than 40 years ago. Together with p107 (also known as RBL1) and p130 …
described more than 40 years ago. Together with p107 (also known as RBL1) and p130 …
Understanding Retinoblastoma Post-Translational Regulation for the Design of Targeted Cancer Therapies.
R Janostiak, A Torres-Sanchez, F Posas, E de Nadal - Cancers, 2022 - europepmc.org
The retinoblastoma protein (Rb1) is a prototypical tumor suppressor protein whose role was
described more than 40 years ago. Together with p107 (also known as RBL1) and p130 …
described more than 40 years ago. Together with p107 (also known as RBL1) and p130 …